Journal of Cancer Research and Clinical Oncology · 2017 · 24 citations · 22 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCell-mediated ImmunityHumoral ImmunityReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsChronic Myeloid Leukemia TherapyHumoral Immunity ImpairmentTherapeutic Tyrosine Kinase InhibitorsTyrosine Kinase InhibitionTyrosine Kinase Inhibitor TherapyTyrosine Kinase Receptor Signaling
22
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text
Medicine, Hematology, Oncology +13
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text
Medicine, Hematology, Pharmacology +15